Register
US FDA permits marketing of AI-based device to screen for diabetic retinopathy |
Journal Updates
eMediNexus Coverage from: 
US FDA permits marketing of AI-based device to screen for diabetic retinopathy
eMediNexus,  12 April 2018
remove_red_eye 803 Views
#Business And Medicine #Diabetes and Endocrinology #Ophthalmology #Pharmacist

0 Read Comments                

The US Food and Drug Administration has permitted marketing of the first medical device ‘IDx-DR’ to use artificial intelligence to detect greater than a mild level of diabetic retinopathy in adults who have diabetes. If the images are of sufficient quality, the software provides the doctor with one of two results: (1) “more than mild diabetic retinopathy detected: refer to an eye care professional” or (2) “negative for more than mild diabetic retinopathy; rescre
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!